Advertisement

Reactions Weekly

, Volume 1635, Issue 1, pp 19–19 | Cite as

Adalimumab

Multi-dermatomal herpes zoster: case report
Case report
  • 20 Downloads

Reference

  1. Agarwal M, et al. Use, safety and efficacy of ZRC 3197, a biosimilar candidate for reference adalimumab (HUMIRA) from a tertiary pediatric rheumatology centre in India. Arthritis and Rheumatology 68: 497-498, Oct 2016. Available from: URL: http://doi.org/10.1002/art.39977 [abstract] - IndiaGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations